Table 1. Clinical Characteristics.
* 1 response missing
| Variable | ECG Monitoring Group (N = 23) | Control Group (N=23) | P Value |
| Age (mean + SD, years) | 55 + 10 | 55 + 9 | --- |
| # (%) | # (%) | ||
| Males | 15 (71%) | 15 (71%) | --- |
| Previous Cardioversion | 16 (70%) | 13 (57%) | 0.54 |
| Cardiac Ablation | 10 (43%) | 11 (48%) | 1.0 |
| Coronary Artery Disease | 3 (13%) | 3 (13%) | 1.0 |
| Stroke/TIA | 3 (13%) | 0 (0%) | 0.23 |
| Congestive Heart Failure | 6 (26%) | 3 (13%) | 0.46 |
| CHA2DS2-VASc > 1 | 5 (22%) | 3 (13%) | 0.70 |
| Diabetes | 1 (4%) | 3 (13%) | 0.61 |
| Hypertension | 11 (48%) | 13 (57%) | 0.77 |
| Obesity | 9 (39%) | 15 (65%) | 0.14 |
| History of Smoking | 9 (39%) | 3 (13%) | 0.09 |
| Medications | |||
| Anticoagulants | 22 (96%) | 20 (87%) | 0.61 |
| Beta Blockers | 15 (68%)* | 19 (83%) | 0.31 |
| Antiarrhythmics | 10 (43%) | 11 (48%) | 1.0 |
| Diuretics | 6 (26%) | 4 (17%) | 0.72 |
| Calcium Channel Blockers | 5 (22%) | 7 (30%) | 0.74 |
| ACE/ARB | 1 (4%) | 4 (17%) | 0.35 |